Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contour Neurovascular System - European Pre-Market Unruptured Aneurysm Study (CERUS)

NCT03680742 is registered in ClinicalTrials.gov with Cerus Endovascular, Inc. as lead sponsor.

NCT NCT03680742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03680742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contour Neurovascular System - European Pre-Market Unruptured Aneurysm Study (CERUS)
Lead sponsor
Cerus Endovascular, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 18, 2018
Completion date
February 2, 2021
Enrollment
34 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm